Ümit Yaşar
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Drug-Induced Hepatotoxicity and Protection
- Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Pharmacology 35
- Pharmacogenetics and Drug Metabolism 35
- Inflammatory mediators and NSAID effects 10
- Oncology 21
- Drug Transport and Resistance Mechanisms 15
- Co-authors
- Erik Eliasson (10 shared papers)Magnus Ingelman‐Sundberg (4 shared papers)Marja‐Liisa Dahl (7 shared papers)Anders Rane (9 shared papers)Gunnel Tybring (6 shared papers)Folke Sjöqvist (4 shared papers)Atilla Bozkurt (35 shared papers)Marja-Liisa Dahl (2 shared papers)
- Journals
- Basic & Clinical Pharmacology & Toxicology (8 papers)European Journal of Clinical Pharmacology (7 papers)The FASEB Journal (4 papers)Xenobiotica (3 papers)Biochemical and Biophysical Research Communications (3 papers)
- Partner nations
- TürkiyeSwedenUnited States
In The Last Decade
Ümit Yaşar
69 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 99
- Pharmacology 1.5k
- Biochemistry 363
- Oncology 800
- Pharmacology 433
- Endocrinology, Diabetes and Metabolism 340
Countries citing papers authored by Ümit Yaşar
This map shows the geographic impact of Ümit Yaşar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ümit Yaşar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ümit Yaşar more than expected).
Fields of papers citing papers by Ümit Yaşar
This network shows the impact of papers produced by Ümit Yaşar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ümit Yaşar. The network helps show where Ümit Yaşar may publish in the future.
Co-authors
The 25 scholars most cited alongside Ümit Yaşar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 226 | |
| 2 | 2003 | 180 | |
| 3 | 2001 | 178 | |
| 4 | 2002 | 146 | |
| 5 | Role of CYP2C9 polymorphism in losartan oxidation. | 2001 | 126 |
| 6 | 2002 | 114 | |
| 7 | 2003 | 92 | |
| 8 | 2001 | 90 | |
| 9 | 2005 | 85 | |
| 10 | 2002 | 83 | |
| 11 | 2003 | 81 | |
| 12 | 2003 | 61 | |
| 13 | Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever. | 2007 | 60 |
| 14 | 2008 | 57 | |
| 15 | 2002 | 44 | |
| 16 | 2011 | 37 | |
| 17 | 2004 | 37 | |
| 18 | 2003 | 37 | |
| 19 | 2007 | 33 | |
| 20 | 2006 | 30 |
About Ümit Yaşar
Ümit Yaşar is a scholar working on Pharmacology, Oncology, Pharmacology, Pediatrics, Perinatology and Child Health and Ophthalmology, having authored 71 papers that have together received 2.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (35 papers), Drug Transport and Resistance Mechanisms (15 papers), Inflammatory mediators and NSAID effects (10 papers), Ocular Infections and Treatments (8 papers), Pharmacological Effects and Toxicity Studies (7 papers), Intraocular Surgery and Lenses (7 papers), Ocular Diseases and Behçet’s Syndrome (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). The work is most often cited by research in Pharmacology (1.5k citations), Biochemistry (363 citations), Oncology (800 citations), Pharmacology (433 citations) and Endocrinology, Diabetes and Metabolism (340 citations). Ümit Yaşar has collaborated with scholars based in Türkiye, Sweden and United States. Frequent co-authors include Erik Eliasson, Magnus Ingelman‐Sundberg, Marja‐Liisa Dahl, Anders Rane, Gunnel Tybring, Folke Sjöqvist, Atilla Bozkurt, Marja-Liisa Dahl, Melih O. Babaoğlu and Moustapha Hassan. Their work appears in journals such as Basic & Clinical Pharmacology & Toxicology, European Journal of Clinical Pharmacology, The FASEB Journal, Xenobiotica and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.